Amgen (AMGN)

A British charitable trust filed a patent infringement suit against Amgen and Wyeth on Wednesday over their blockbuster Enbrel drug, one of the world's best-selling treatments for rheumatoid arthritis.
The Mathilda and Terence Kennedy Institute of Rheumatology Trust asked a federal court in Delaware to grant royalty payments and damages from Wyeth and Amgen for infringing a patent for treating arthritis.

Oct 28 · 12:28:00 PM · Source: Reuters
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto